Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Tract Infection I: Introduction01:26

Urinary Tract Infection I: Introduction

698
Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
698
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

750
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
750
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

483
In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
483
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

318
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
318
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

1.5K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.5K
Urinary Tract Calculi I: Introduction01:28

Urinary Tract Calculi I: Introduction

542
Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...
542

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of risk factors for hospital-onset bacteremia to inform a routine data based risk prediction - an umbrella review.

The Journal of hospital infection·2026
Same author

[Development of the epidemiology of antibiotic-resistant pathogens in human medicine and their significance for the health system in Germany].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same author

Surveillance of antimicrobial resistance by a global network of WHO collaborating centres.

Bulletin of the World Health Organization·2026
Same author

Lessons from Two Early COVID-19 Hospital Outbreaks in Germany to Inform Strategies for Controlling Emerging Nosocomial Outbreaks of Highly Transmissible Respiratory Viruses.

Journal of clinical medicine·2026
Same author

Integrated genomic surveillance: paths that can be taken.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same author

International spread or local outbreak? Epidemiologic analyses of transmission patterns of NDM-1-producing <i>Klebsiella pneumoniae</i> based on genomic surveillance data, Germany, January 2022 to February 2023.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026

Related Experiment Video

Updated: Feb 6, 2026

Transurethral Induction of Mouse Urinary Tract Infection
09:24

Transurethral Induction of Mouse Urinary Tract Infection

Published on: August 5, 2010

37.4K

Antibiotic-Resistant E. coli in Uncomplicated Community-Acquired Urinary Tract Infection.

Anja Klingeberg1, Ines Noll, Niklas Willrich

  • 1Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany; Charité-Universitätsmedizin Berlin, Germany; LADR GmbH, Medizinisches Versorgungszentrum Plön, Germany; MVZ Dr. Stein und Kollegen GbR, Mönchengladbach, Germany; MVZ Labor Dr.Limbach & Kollegen GbR, Heidelberg, Germany; Medizinisches Versorgungszentrum, Labor 28 GmbH, Berlin, Germany; Department for Health Services Research, Institute for Public Health and Nursing Science, Bremen, Germany.

Deutsches Arzteblatt International
|August 24, 2018
PubMed
Summary

Trimethoprim (TMP) is effective for uncomplicated urinary tract infections (UTIs), with lower Escherichia coli resistance than previously thought. Routine surveillance data may not accurately reflect UTI resistance patterns in these patients.

More Related Videos

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection
07:57

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection

Published on: June 24, 2025

1.2K
Longitudinal Follow-Up of Urinary Tract Infections and Their Treatment in Mice using Bioluminescence Imaging
07:39

Longitudinal Follow-Up of Urinary Tract Infections and Their Treatment in Mice using Bioluminescence Imaging

Published on: June 14, 2021

3.5K

Related Experiment Videos

Last Updated: Feb 6, 2026

Transurethral Induction of Mouse Urinary Tract Infection
09:24

Transurethral Induction of Mouse Urinary Tract Infection

Published on: August 5, 2010

37.4K
An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection
07:57

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection

Published on: June 24, 2025

1.2K
Longitudinal Follow-Up of Urinary Tract Infections and Their Treatment in Mice using Bioluminescence Imaging
07:39

Longitudinal Follow-Up of Urinary Tract Infections and Their Treatment in Mice using Bioluminescence Imaging

Published on: June 14, 2021

3.5K

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • Routine urine culture testing is often not performed for uncomplicated urinary tract infections (UTIs).
  • This lack of routine data hinders accurate reflection of antibiotic resistance patterns and causative organisms in UTIs.
  • Community-acquired UTIs require updated insights into pathogen susceptibility.

Purpose of the Study:

  • To investigate the antibiotic resistance of Escherichia coli (E. coli) to trimethoprim (TMP) and trimethoprim/sulfamethoxazole (TMP/SMX) in community-acquired UTIs.
  • To compare these resistance findings with data from the Antimicrobial Resistance Surveillance System (ARS).
  • To evaluate the suitability of TMP for treating uncomplicated UTIs based on current resistance levels.

Main Methods:

  • Prospective recruitment of adult patients with UTI symptoms from general practitioners and internists.
  • Collection and testing of urine specimens, including culture and antibiotic susceptibility testing.
  • Classification of UTIs as uncomplicated or complicated based on established criteria.

Main Results:

  • Out of 1245 participants, 877 had pathogenic organisms, with E. coli identified in 74.5%.
  • In uncomplicated UTIs, E. coli resistance to TMP was 15.2% and to TMP/SMX was 13.0%.
  • These rates were lower than the 25.3% (TMP) and 24.4% (TMP/SMX) reported in ARS routine data for 2015.

Conclusions:

  • E. coli resistance to TMP in uncomplicated UTIs is lower than suggested by routine surveillance data.
  • TMP remains a viable treatment option for uncomplicated UTIs.
  • Routine surveillance data may not be representative for assessing resistance in uncomplicated UTI cases.